Closing the Assay Loop: Inside Anthropic's $400M Wet Lab Pivot
Dr. Dereck Mush, MD, MBA
Coefficient Bio
AI drug discovery company acquired by Anthropic and integrated into its life sciences team.
What they do
Founded by Aris Theologis, Nathan C. Frey, Samuel Stanton and Joyce Hong, Coefficient Bio brought generative biology and scientific AI expertise to Anthropic through a reported April 2026 stock acquisition worth about $400 million.
The record
- Vertical
- Pharma & Drug Discovery
- Sub-segment
- Generative biology
- Product type
- Platform software
- Stage
- Growth
- Headquarters
- New York, NY, USA
- Region
- North America
- Founded
- 2025
- Total funding
- Undisclosed
Notable investors: Dimension.
Also in Pharma & Drug Discovery
Related on The Signal
Dr. Dereck Mush, MD, MBA
What Pharma Is Buying From AI Drug Discovery: Inside AstraZeneca’s insitro Deal
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
Chai Discovery triples its valuation as pharma buys into AI-designed molecules
Chai Discovery triples its valuation as pharma buys into AI-designed molecules
Dr. Dereck Mush, MD, MBA
AI is moving upstream, from molecule design into disease target identification itself
Dr. Dereck Mush, MD, MBA